Document Detail


Reduced lung uptake of iodine-123 metaiodobenzylguanidine in high-altitude pulmonary oedema.
MedLine Citation:
PMID:  18657059     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND OBJECTIVE: Iodine-123 metaiodobenzylguanidine ((123)I-MIBG) uptake in the lungs is a potentially suitable marker of pulmonary endothelial function because MIBG behaviour in the pulmonary circulation is quantitatively similar to that of norepinephrine. In addition, hypoxia reduces (123)I-MIBG transport in pulmonary endothelial cells in vitro. The present study was undertaken to evaluate (123)I-MIBG uptake in the lungs of patients with high-altitude pulmonary oedema (HAPE). METHODS: (123)I-MIBG scintigraphy was performed in eight patients with HAPE. The findings were compared with those in 24 patients with congestive heart failure due to idiopathic dilated cardiomyopathy (DCM) and in 13 normal control subjects. In patients with HAPE, the (123)I-MIBG examination was performed 7-14 days after admission. Anterior planar images were acquired 15 min after injection of (123)I-MIBG and the total lung to upper mediastinum ratio (L/M ratio) was calculated for both lungs. RESULTS: The L/M ratio in patients with HAPE (1.39 +/- 0.15, mean +/- SD) was significantly lower than in those with congestive heart failure/DCM (1.66 +/- 0.16) or in normal controls (1.53 +/- 0.14). There were no significant differences among the groups in (123)I-MIBG accumulation in the heart. CONCLUSIONS: Although the mechanism of altered (123)I-MIBG kinetics in HAPE remains obscure, decreased (123)I-MIBG uptake in the lungs may potentially be a suitable technique for the assessment of pathological conditions associated with the pulmonary endothelium.
Authors:
Kazuhisa Urushihata; Tomonobu Koizumi; Masayuki Hanaoka; Keisaku Fujimoto; Keishi Kubo; Toshio Kobayashi; Tadashige Fujii
Related Documents :
14757909 - Respiratory control during postural changes in anesthetized cats.
7793219 - Healthy lungs tolerate repetitive collapse and reopening during short periods of mechan...
1890489 - Asbestosis: diagnostic dilution.
1440459 - Lung sound intensity in patients with emphysema and in normal subjects at standardised ...
6640409 - Mucociliary clearance from the calf lung.
7820979 - Biphasic pulmonary clearance of 99mtc-dtpa in smokers.
21933039 - Effects of concurrent training on interleukin-6, tumour necrosis factor-alpha and c-rea...
21165439 - Expression of kir2dl3 and kir2ds2 natural killer receptors in exercise.
14649359 - Effect of controlled exercise on middle gluteal muscle fibre composition in thoroughbre...
Publication Detail:
Type:  Journal Article     Date:  2008-07-24
Journal Detail:
Title:  Respirology (Carlton, Vic.)     Volume:  13     ISSN:  1440-1843     ISO Abbreviation:  Respirology     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-09-24     Completed Date:  2009-02-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9616368     Medline TA:  Respirology     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  897-902     Citation Subset:  IM    
Affiliation:
First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
3-Iodobenzylguanidine / pharmacokinetics*
Adult
Altitude*
Endothelium, Vascular / physiopathology
Female
Heart Failure / metabolism
Humans
Lung / metabolism*,  physiopathology
Male
Middle Aged
Pulmonary Edema / metabolism*,  physiopathology,  radionuclide imaging
Radiopharmaceuticals / pharmacokinetics*
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 77679-27-7/3-Iodobenzylguanidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pleural effusion in patients with pulmonary embolism.
Next Document:  Revision of the severity rating and classification of hospital-acquired pneumonia in the Japanese Re...